Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Other financing activities (2020 - 2023)

Tango Therapeutics (TNGX) has 2 years of Other financing activities data on record, last reported at $63000.0 in Q4 2023.

  • For Q4 2023, Other financing activities changed N/A year-over-year to $63000.0; the TTM value through Dec 2023 reached $7.2 million, changed N/A, while the annual FY2025 figure was $36000.0, N/A changed from the prior year.
  • Other financing activities reached $63000.0 in Q4 2023 per TNGX's latest filing, down from $3.6 million in the prior quarter.
  • Across five years, Other financing activities topped out at $3.6 million in Q3 2020 and bottomed at $63000.0 in Q4 2023.